AR062835A1 - Una composicon estimulante selectiva de la cicatrizacion su preparcion y aplicacion - Google Patents

Una composicon estimulante selectiva de la cicatrizacion su preparcion y aplicacion

Info

Publication number
AR062835A1
AR062835A1 ARP070103846A ARP070103846A AR062835A1 AR 062835 A1 AR062835 A1 AR 062835A1 AR P070103846 A ARP070103846 A AR P070103846A AR P070103846 A ARP070103846 A AR P070103846A AR 062835 A1 AR062835 A1 AR 062835A1
Authority
AR
Argentina
Prior art keywords
preparation
cicatrization
application
stimulating composition
selective stimulating
Prior art date
Application number
ARP070103846A
Other languages
English (en)
Inventor
Andrea Giuliani
Ana Cruces
Walter Montagni
Rosalia Mlynarz
Patricia Duarte
Original Assignee
Walter Montagni
Rosalia Mlynarz
Ana Cruces
Andrea Giuliani
Patricia Duarte
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Walter Montagni, Rosalia Mlynarz, Ana Cruces, Andrea Giuliani, Patricia Duarte filed Critical Walter Montagni
Priority to ARP070103846A priority Critical patent/AR062835A1/es
Priority to PCT/IB2008/002346 priority patent/WO2009027823A2/en
Publication of AR062835A1 publication Critical patent/AR062835A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/22—Cysteine endopeptidases (3.4.22)
    • C12Y304/22002—Papain (3.4.22.2)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Composicion química compuesta por gentamicina, metronidazol, papaina, bálsamo del Peru, lanolina y vaselina solida, para el tratamiento de heridas y otras lesiones cutáneas en medicina humana, veterinaria y tratamientos odontologicos. Preparacion y uso.
ARP070103846A 2007-08-29 2007-08-29 Una composicon estimulante selectiva de la cicatrizacion su preparcion y aplicacion AR062835A1 (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ARP070103846A AR062835A1 (es) 2007-08-29 2007-08-29 Una composicon estimulante selectiva de la cicatrizacion su preparcion y aplicacion
PCT/IB2008/002346 WO2009027823A2 (en) 2007-08-29 2008-08-29 Pharmaceutical composition for selective stimulation of wound healing processes, dermal-epidermal normal tissular trophism processes, its preparation and application.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ARP070103846A AR062835A1 (es) 2007-08-29 2007-08-29 Una composicon estimulante selectiva de la cicatrizacion su preparcion y aplicacion

Publications (1)

Publication Number Publication Date
AR062835A1 true AR062835A1 (es) 2008-12-10

Family

ID=40225122

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070103846A AR062835A1 (es) 2007-08-29 2007-08-29 Una composicon estimulante selectiva de la cicatrizacion su preparcion y aplicacion

Country Status (2)

Country Link
AR (1) AR062835A1 (es)
WO (1) WO2009027823A2 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2663335A1 (en) * 2011-01-13 2013-11-20 Medestea Internazionale S.p.A. A composition for the regeneration of atrophic tissues
CN102241712B (zh) * 2011-05-23 2014-04-02 南阳普康药业有限公司 一种硫酸庆大霉素生产脱色方法
CN104435345A (zh) * 2014-11-11 2015-03-25 四川金堂海纳生物医药技术研究所 一种治疗牙髓炎的内服药物及其制备方法
BE1024364B9 (nl) * 2016-06-29 2018-03-07 Holding Tolpoort Bvba Samenstelling voor behandeling van perniosis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189650C (nl) * 1978-05-30 1993-06-16 Ace Veterinary Products B V Farmaceutische preparaten voor het behandelen van wonden.
WO2000038617A2 (en) * 1998-12-24 2000-07-06 Four Star Partners Compositions and methods of using the same
US20040151765A1 (en) * 2001-09-18 2004-08-05 Ritchie Branson W. Methods and compositions for wound management
US20040076671A1 (en) * 2002-10-21 2004-04-22 Aletha Tippett Methods and compositions for topical wound treatment
EP3871693A1 (en) * 2005-09-27 2021-09-01 Special Water Patents B.V. Compositions for oral care
EP2108360A3 (en) * 2005-10-24 2010-06-09 Collegium Pharmaceutical, Inc. Topical Pharmaceutical Foam Composition
WO2007084127A1 (en) * 2006-01-20 2007-07-26 Verdon Peters Use of gluten for wound treatment as active healing ingredient

Also Published As

Publication number Publication date
WO2009027823A2 (en) 2009-03-05
WO2009027823A3 (en) 2009-04-23
WO2009027823A9 (en) 2009-09-03

Similar Documents

Publication Publication Date Title
EA201100335A1 (ru) Производные пурина для применения при лечении связанных с fab заболеваний
CL2016000530A1 (es) Tratamiento de la osteoartritis y del dolor (divisional de sol. n°2298-13).
CL2012002326A1 (es) Uso de una combinación de por lo menos un agente quimioterapéutico y una cantidad efectiva de un anticuerpo anti-vegf (factor de crecimiento endotelial vascular), porque sirve para preparar un medicamento útil en el tratamiento de cáncer ovárico; y su kit para tratar el cáncer ovárico sin tratamiento anterior en una paciente humana.
AR086051A1 (es) Metodo para tratar el cancer colorrectal, composicion que comprende aflibercept, acido folinico, 5-fluorouracilo (5-fu) e irinotecano (folfiri), articulo manufacturado, kit
ECSP12011943A (es) Antagonistas de espiro-oxindol de mdm2
BRPI0923589A2 (pt) uso de uma composição espumável essencialmente livre de ingredientes farmaceuticamente ativos para o tratamento da pele humana.
ES2530417T3 (es) Dispositivo de apósito para su uso con una cánula o un catéter
CL2010001260A1 (es) Composicion farmaceutica que comprende una sal de estroncio y vitamina d y una ciclodextrina, donde la relacion masica entre la cantidad de vitamina d y la cantidad de ciclodextrina esta comprendida entre 1/40 y 1/800, util para tratar o prevenir osteoporosis.
AR061170A1 (es) Proteinas que se unen con el factor de crecimiento de hepatocitos (hgf)
UY32882A (es) (heteroarilmetil) tiohidantoínas sustituidas
WO2009075882A3 (en) Impaired wound healing compositions and treatments
CL2009001077A1 (es) Vehiculo particulado polimerico que comprende un agente biologico en fase acuosa en un lumen hueco; procedimiento para suministrar una proteina en el ojo; composicion farmaceutica que comprende dicho vehiculo; y su uso para profilaxis y tratar enfermedades o trastornos del ojo.
ECSP066805A (es) Compuestos silinano como inhibidores de cisteína proteasa
UY30158A1 (es) Uso de derivados de benzo-heteroaril sulfamida para el tratamiento del dolor
CL2008002545A1 (es) Compuestos derivados de fenoxi-bencil-carbamoilo; composicion farmaceutica; procedimiento para preparar la composicion farmaceutica; y su uso en el tratamiento del dolor.
GT200900319A (es) (oxazolidinon-5-il-metil)-2-tiofen-carboxamidas sustituidas y su uso en el campo de la coagulación sanguínea
CL2012003266A1 (es) Polisacarido de semillas de tamarindo para usarse en el tratamiento de infecciones microbianas; composicion farmacéutica y/o dermocosmética antimicrobiana que contiene dicho polisacárido; uso de un polisacárido de semilla de tamarindo ; metodo para tratar y/o prevenir a un paciente que tiene una infeccion microbiana.
AR062835A1 (es) Una composicon estimulante selectiva de la cicatrizacion su preparcion y aplicacion
CO2019003865A2 (es) Proteína terapéutica
DOP2017000055A (es) Tratamientos médicos a base de anamorelina
CO6761349A2 (es) Proteína antimicrobiana
UY31717A1 (es) (pirazolilcarbonil) imidazolidinonas sustituidas y su uso
AR084499A1 (es) Un dispositivo intramedular descartable de uso transitorio para el tratamiento de infecciones en extremidades
SV2010003578A (es) Oxazolidinonas para el tratamiento y profilaxis de la insuficiencia cardiaca
CY1120727T1 (el) Συνδυασμοι με ενα πεπτιδιο κυκλοποιημενου σκελετου

Legal Events

Date Code Title Description
FC Refusal